Excel · study · 2026
NAD⁺ Augmentation by Nicotinamide Riboside Engages SLIT2/ROBO1 Signaling to Attenuate Th17 Inflammation in Psoriasis
Listed in NCBI GEO
BACKGROUND.
Description
Enhancing NAD+ level by Nicotinamide Riboside (NR) supplementation confer anti-inflammatory effects in human disease, yet the immunoregulatory mechanisms remain unclear. We previously demonstrated ex vivo study that NR blunts CD4+ T cell immune responsiveness in psoriasis.
To explore whether these effects occur in vivo, we conducted a randomized, placebo-controlled NR supplementation study in participants with mild-tomoderate- psoriasis. METHODS. Psoriasis participants consumed oral NR supplementation (500 mg twice daily) or matching placebo for 4 weeks.
Read the rest (3 more)
Research bloods were drawn at baseline and at 4 weeks for analysis. In parallel, natural history cohorts of healthy controls and psoriasis participants donated research blood and skin punch biopsies for mechanistic analysis. RESULTS.
Oral NR supplementation dampens Th17 immune responsiveness. Bulk RNA-seq of CD4+ cells identified that NR regulated the SLIT-ROBO signaling pathway. Participants on NR showed elevated circulating SLIT2 levels, and NR increased SLIT2 production in skin fibroblasts.
Pharmacologic and genetic studies in CD4+ T cells and fibroblasts showed that SLIT2, acting through the ROBO1 receptor, inhibited Rho GTPase signaling, thereby reducing canonical Th17 polarization and fibroblast inflammatory activation. CONCLUSION. NAD+ augmentation confers anti-inflammatory effects in psoriasis through SLIT2/ROBO1-mediated crosstalk between dermal fibroblast and circulating CD4+ T cells, leading to attenuation of Th17-driven inflammation.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE314nnn/GSE314390 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314390 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1390800 ncbi.nlm.nih.gov/bioproject/PRJNA1390800 ↗
project · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Homo sapiens
- From keywords
- Life Sciences
- Inferred from text
- Disease 75% · RNA sequencing 65%
Provenance · 1 source records, 9 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE314390 | 13 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:disease | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[modality].local:modality:rna-seq | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[organism].NCBITaxon:9606 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |